Concurrently, Moody’s affirmed its “A2” rating on the health system’s outstanding bonds, affecting about $940 million of debt.
The affirmation and assignment are based on several factors, including the health system’s growing market position, reliable operating performance, characterized by a strong annual cash flow, favorable fundraising capabilities and improving liquidity metrics.
The outlook was revised to positive from stable, reflecting the health system’s strong cash flow generation, which will lead to leverage improvements.
More articles on healthcare finance:
Many Americans struggling to meet basic needs, including healthcare
Georgia health system names revenue cycle VP: 4 things to know
This week’s 5 must-reads for hospital RCM leaders
